Upper extremity deep vein thrombosis: Clinical and treatment characteristics

Creative Commons License

Karabay O., Yetkin U., Onol H.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, cilt.32, sa.4, ss.429-435, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 4
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1177/147323000403200413
  • Dergi Adı: JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.429-435
  • Anahtar Kelimeler: deep venous thrombosis, upper extremity, ultrasonography, colour Doppler, low molecular weight heparin, INTRAVENOUS UNFRACTIONATED HEPARIN, SUBCLAVIAN VENOUS THROMBOSIS, MOLECULAR-WEIGHT HEPARIN, FOLLOW-UP EVALUATION, AXILLARY, VENOGRAPHY, CATHETERS, THERAPY
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

We aimed to evaluate patients with upper extremity deep vein thrombosis (UEDVT) in terms of the risk factors, symptoms, clinical course, diagnostic approaches and treatment outcome. Thirty-six patients with a diagnosis of UEDVT, comprising 19 males (52.7%) and 17 females (47.3%), were included in the study; the mean ( +/- SD) age was 54 +/- 12.3 years. The most common risk factor was central venous catheter use. The treatment protocol consisted of low molecular weight heparin for up to 7 days, followed by oral anticoagulants for up to 6 months. All patients were followed up for 1 year. More than 90% of the patients responded well to treatment. Nine patients (25%) died due to underlying diseases; no patients died secondary to UEDVT. None of the patients developed pulmonary embolus or recurrent deep venous thrombosis, and post-thrombotic syndrome was not observed. The mortality rate was related to the underlying diseases.